7,8-Dihydroneopterin induces apoptosis of Jurkat T-lymphocytes via a Bcl-2-sensitive pathway

Eur J Cell Biol. 2002 Apr;81(4):197-202. doi: 10.1078/0171-9335-00236.

Abstract

Activated cell-mediated immunity is known to be accompanied by elevated concentrations of 7,8-dihydroneopterin which in high concentrations was found to interfere with the oxidant-antioxidant balance. In this study we investigated whether 7,8-dihydroneopterin mediates apoptosis of Jurkat T-lymphocytes via a CrmA- or Bcl-2-sensitive pathway. Transient transfection assays with CrmA and Bcl-2 expression constructs showed that apoptosis was not affected by CrmA whereas it was significantly decreased upon cotransfection with Bcl-2 constructs. Results suggest that 7,8-dihydroneopterin-induced apoptosis of T-lymphocytes is mediated by a Bcl-2-sensitive pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Apoptosis / drug effects*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Jurkat Cells
  • Mitogen-Activated Protein Kinases / metabolism
  • Neopterin / analogs & derivatives
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Pteridines / pharmacology*
  • Serpins / genetics
  • Serpins / metabolism
  • Signal Transduction / physiology*
  • Staurosporine / pharmacology
  • Viral Proteins*

Substances

  • Antioxidants
  • Enzyme Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • Pteridines
  • Serpins
  • Viral Proteins
  • 7,8-dihydroneopterin
  • Neopterin
  • interleukin-1beta-converting enzyme inhibitor
  • Mitogen-Activated Protein Kinases
  • Staurosporine